Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Elevance Health Inc. gross profit margin ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023. |
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Elevance Health Inc. operating profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Elevance Health Inc. net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Elevance Health Inc. ROE deteriorated from 2021 to 2022 and from 2022 to 2023. |
ROA | A profitability ratio calculated as net income divided by total assets. | Elevance Health Inc. ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |
Gross Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Gross profit | 28,586) | 26,138) | 23,403) | 23,810) | 19,363) | |
Operating revenue | 170,209) | 155,660) | 136,943) | 120,808) | 103,141) | |
Profitability Ratio | ||||||
Gross profit margin1 | 16.79% | 16.79% | 17.09% | 19.71% | 18.77% | |
Benchmarks | ||||||
Gross Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 50.28% | 51.54% | 52.21% | 50.49% | 52.46% | |
Cigna Group | 12.37% | 12.44% | 12.41% | 14.43% | 15.57% | |
CVS Health Corp. | 14.94% | 16.62% | 17.48% | 18.01% | 17.41% | |
Intuitive Surgical Inc. | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | |
Medtronic PLC | 65.67% | 67.98% | 65.19% | 67.41% | 70.04% | |
UnitedHealth Group Inc. | 23.64% | 24.09% | 23.60% | 25.62% | 23.19% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Gross profit margin = 100 × Gross profit ÷ Operating revenue
= 100 × 28,586 ÷ 170,209 = 16.79%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Elevance Health Inc. gross profit margin ratio deteriorated from 2021 to 2022 but then slightly improved from 2022 to 2023. |
Operating Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Operating income | 7,614) | 7,685) | 7,048) | 5,999) | 5,661) | |
Operating revenue | 170,209) | 155,660) | 136,943) | 120,808) | 103,141) | |
Profitability Ratio | ||||||
Operating profit margin1 | 4.47% | 4.94% | 5.15% | 4.97% | 5.49% | |
Benchmarks | ||||||
Operating Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 16.15% | 19.16% | 19.56% | 15.48% | 14.21% | |
Cigna Group | 4.40% | 4.69% | 4.60% | 5.12% | 5.31% | |
CVS Health Corp. | 3.85% | 2.41% | 4.54% | 5.19% | 4.69% | |
Humana Inc. | 3.81% | 4.11% | 3.80% | 6.56% | 4.96% | |
Intuitive Surgical Inc. | 24.80% | 25.35% | 31.89% | 24.09% | 30.69% | |
Medtronic PLC | 17.56% | 18.15% | 14.89% | 16.57% | 20.51% | |
UnitedHealth Group Inc. | 8.80% | 8.83% | 8.40% | 8.76% | 8.19% | |
Operating Profit Margin, Sector | ||||||
Health Care Equipment & Services | 6.29% | 6.23% | 6.69% | 7.04% | 6.89% | |
Operating Profit Margin, Industry | ||||||
Health Care | 9.29% | 13.11% | 13.07% | 10.36% | 12.35% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Operating profit margin = 100 × Operating income ÷ Operating revenue
= 100 × 7,614 ÷ 170,209 = 4.47%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Elevance Health Inc. operating profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Net Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Shareholders’ net income | 5,987) | 6,025) | 6,104) | 4,572) | 4,807) | |
Operating revenue | 170,209) | 155,660) | 136,943) | 120,808) | 103,141) | |
Profitability Ratio | ||||||
Net profit margin1 | 3.52% | 3.87% | 4.46% | 3.78% | 4.66% | |
Benchmarks | ||||||
Net Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 14.27% | 15.88% | 16.42% | 12.99% | 11.56% | |
Cigna Group | 2.66% | 3.72% | 3.11% | 5.31% | 3.35% | |
CVS Health Corp. | 2.34% | 1.29% | 2.72% | 2.68% | 2.59% | |
Humana Inc. | 2.36% | 3.03% | 3.54% | 4.43% | 4.20% | |
Intuitive Surgical Inc. | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | |
Medtronic PLC | 12.03% | 15.90% | 11.97% | 16.56% | 15.16% | |
UnitedHealth Group Inc. | 6.09% | 6.25% | 6.06% | 6.03% | 5.76% | |
Net Profit Margin, Sector | ||||||
Health Care Equipment & Services | 4.37% | 4.60% | 4.96% | 5.21% | 4.85% | |
Net Profit Margin, Industry | ||||||
Health Care | 7.95% | 10.17% | 10.82% | 7.69% | 10.13% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Net profit margin = 100 × Shareholders’ net income ÷ Operating revenue
= 100 × 5,987 ÷ 170,209 = 3.52%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Elevance Health Inc. net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Return on Equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Shareholders’ net income | 5,987) | 6,025) | 6,104) | 4,572) | 4,807) | |
Shareholders’ equity | 39,306) | 36,307) | 36,060) | 33,199) | 31,728) | |
Profitability Ratio | ||||||
ROE1 | 15.23% | 16.59% | 16.93% | 13.77% | 15.15% | |
Benchmarks | ||||||
ROE, Competitors2 | ||||||
Abbott Laboratories | 14.83% | 18.90% | 19.75% | 13.71% | 11.86% | |
Cigna Group | 11.17% | 14.86% | 11.39% | 16.81% | 11.26% | |
CVS Health Corp. | 10.91% | 5.84% | 10.54% | 10.35% | 10.39% | |
Humana Inc. | 15.31% | 18.33% | 18.24% | 24.53% | 22.49% | |
Intuitive Surgical Inc. | 13.51% | 11.98% | 14.32% | 10.90% | 16.69% | |
Medtronic PLC | 7.30% | 9.59% | 7.01% | 9.44% | 9.25% | |
UnitedHealth Group Inc. | 25.22% | 25.87% | 24.09% | 23.52% | 24.02% | |
ROE, Sector | ||||||
Health Care Equipment & Services | 15.02% | 15.36% | 15.06% | 15.16% | 14.26% | |
ROE, Industry | ||||||
Health Care | 17.95% | 22.36% | 22.87% | 16.00% | 21.03% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROE = 100 × Shareholders’ net income ÷ Shareholders’ equity
= 100 × 5,987 ÷ 39,306 = 15.23%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Elevance Health Inc. ROE deteriorated from 2021 to 2022 and from 2022 to 2023. |
Return on Assets (ROA)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Shareholders’ net income | 5,987) | 6,025) | 6,104) | 4,572) | 4,807) | |
Total assets | 108,928) | 102,772) | 97,460) | 86,615) | 77,453) | |
Profitability Ratio | ||||||
ROA1 | 5.50% | 5.86% | 6.26% | 5.28% | 6.21% | |
Benchmarks | ||||||
ROA, Competitors2 | ||||||
Abbott Laboratories | 7.82% | 9.31% | 9.40% | 6.20% | 5.43% | |
Cigna Group | 3.38% | 4.63% | 3.46% | 5.44% | 3.28% | |
CVS Health Corp. | 3.34% | 1.82% | 3.39% | 3.11% | 2.98% | |
Humana Inc. | 5.29% | 6.52% | 6.61% | 9.63% | 9.31% | |
Intuitive Surgical Inc. | 11.64% | 10.19% | 12.58% | 9.50% | 14.17% | |
Medtronic PLC | 4.13% | 5.54% | 3.87% | 5.28% | 5.16% | |
UnitedHealth Group Inc. | 8.18% | 8.19% | 8.15% | 7.81% | 7.96% | |
ROA, Sector | ||||||
Health Care Equipment & Services | 5.50% | 5.63% | 5.63% | 5.61% | 5.18% | |
ROA, Industry | ||||||
Health Care | 6.35% | 8.30% | 8.19% | 5.42% | 7.18% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROA = 100 × Shareholders’ net income ÷ Total assets
= 100 × 5,987 ÷ 108,928 = 5.50%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROA | A profitability ratio calculated as net income divided by total assets. | Elevance Health Inc. ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |